APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mammalian Biopharmaceutical Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mammalian Biopharmaceutical Service Industry Growth and Trends Forecast to 2032

12 August 2026111 pages

Choose your research edition.

Industry ResearchMammalian Biopharmaceutical Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Mammalian Biopharmaceutical Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mammalian Biopharmaceutical Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mammalian Biopharmaceutical Service Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Mammalian Biopharmaceutical Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

According to APO Research, the global Mammalian Biopharmaceutical Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Mammalian Biopharmaceutical Service market include Novartis, KBI Biopharma, 3P Biopharmaceuticals, Sartorius Stedim Biotech, Merck Millipore, Rentschler Biopharma SE, Northway Biotech, Cambrex and Samsung Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mammalian Biopharmaceutical Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mammalian Biopharmaceutical Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mammalian Biopharmaceutical Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mammalian Biopharmaceutical Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Mammalian Biopharmaceutical Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mammalian Biopharmaceutical Service Market by Company

Novartis

KBI Biopharma

3P Biopharmaceuticals

Sartorius Stedim Biotech

Merck Millipore

Rentschler Biopharma SE

Northway Biotech

Cambrex

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

GBI

Thermo Fisher Scientific

Catalent

WuXi Biologics

Boehringer Ingelheim BioXcellence

Lonza

Abzena

AGC Biologics

Mammalian Biopharmaceutical Service Segment by Type

Cell Line Development

Analytical Testing

Technology Transfer

Formulation Development

Others

Mammalian Biopharmaceutical Service Segment by Application

Pharmaceutical

Contract Research Organizations (CROs)

Academic and Research Institutes

Biotechnology Companies

Government Agencies

Mammalian Biopharmaceutical Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mammalian Biopharmaceutical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mammalian Biopharmaceutical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mammalian Biopharmaceutical Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Mammalian Biopharmaceutical Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Mammalian Biopharmaceutical Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Mammalian Biopharmaceutical Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Mammalian Biopharmaceutical Service Market Share by Region (2021-2026) Table 4. Global Mammalian Biopharmaceutical Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Mammalian Biopharmaceutical Service Market Share by Region (2027-2032) Table 6. Global Mammalian Biopharmaceutical Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2026) Table 9. Global Mammalian Biopharmaceutical Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Mammalian Biopharmaceutical Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Mammalian Biopharmaceutical Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2026) Table 24. Global Mammalian Biopharmaceutical Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Mammalian Biopharmaceutical Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Mammalian Biopharmaceutical Service Industry Trends Table 37. Mammalian Biopharmaceutical Service Industry Drivers Table 38. Mammalian Biopharmaceutical Service Industry Opportunities and Challenges Table 39. Mammalian Biopharmaceutical Service Industry Restraints Table 40. Global Mammalian Biopharmaceutical Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Mammalian Biopharmaceutical Service Revenue Market Share by Company (2021-2026) Table 42. Global Mammalian Biopharmaceutical Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Mammalian Biopharmaceutical Service Key Company Headquarters & Area Served Table 44. Global Mammalian Biopharmaceutical Service Company, Product Type & Application Table 45. Global Mammalian Biopharmaceutical Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Mammalian Biopharmaceutical Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Mammalian Biopharmaceutical Service Product Portfolio Table 52. Novartis Recent Development Table 53. KBI Biopharma Company Information Table 54. KBI Biopharma Business Overview Table 55. KBI Biopharma Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. KBI Biopharma Mammalian Biopharmaceutical Service Product Portfolio Table 57. KBI Biopharma Recent Development Table 58. 3P Biopharmaceuticals Company Information Table 59. 3P Biopharmaceuticals Business Overview Table 60. 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product Portfolio Table 62. 3P Biopharmaceuticals Recent Development Table 63. Sartorius Stedim Biotech Company Information Table 64. Sartorius Stedim Biotech Business Overview Table 65. Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product Portfolio Table 67. Sartorius Stedim Biotech Recent Development Table 68. Merck Millipore Company Information Table 69. Merck Millipore Business Overview Table 70. Merck Millipore Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck Millipore Mammalian Biopharmaceutical Service Product Portfolio Table 72. Merck Millipore Recent Development Table 73. Rentschler Biopharma SE Company Information Table 74. Rentschler Biopharma SE Business Overview Table 75. Rentschler Biopharma SE Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product Portfolio Table 77. Rentschler Biopharma SE Recent Development Table 78. Northway Biotech Company Information Table 79. Northway Biotech Business Overview Table 80. Northway Biotech Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Northway Biotech Mammalian Biopharmaceutical Service Product Portfolio Table 82. Northway Biotech Recent Development Table 83. Cambrex Company Information Table 84. Cambrex Business Overview Table 85. Cambrex Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cambrex Mammalian Biopharmaceutical Service Product Portfolio Table 87. Cambrex Recent Development Table 88. Samsung Biologics Company Information Table 89. Samsung Biologics Business Overview Table 90. Samsung Biologics Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Samsung Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 92. Samsung Biologics Recent Development Table 93. FUJIFILM Diosynth Biotechnologies Company Information Table 94. FUJIFILM Diosynth Biotechnologies Business Overview Table 95. FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product Portfolio Table 97. FUJIFILM Diosynth Biotechnologies Recent Development Table 98. GBI Company Information Table 99. GBI Business Overview Table 100. GBI Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GBI Mammalian Biopharmaceutical Service Product Portfolio Table 102. GBI Recent Development Table 103. Thermo Fisher Scientific Company Information Table 104. Thermo Fisher Scientific Business Overview Table 105. Thermo Fisher Scientific Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific Mammalian Biopharmaceutical Service Product Portfolio Table 107. Thermo Fisher Scientific Recent Development Table 108. Catalent Company Information Table 109. Catalent Business Overview Table 110. Catalent Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Catalent Mammalian Biopharmaceutical Service Product Portfolio Table 112. Catalent Recent Development Table 113. WuXi Biologics Company Information Table 114. WuXi Biologics Business Overview Table 115. WuXi Biologics Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. WuXi Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 117. WuXi Biologics Recent Development Table 118. Boehringer Ingelheim BioXcellence Company Information Table 119. Boehringer Ingelheim BioXcellence Business Overview Table 120. Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Product Portfolio Table 122. Boehringer Ingelheim BioXcellence Recent Development Table 123. Lonza Company Information Table 124. Lonza Business Overview Table 125. Lonza Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Lonza Mammalian Biopharmaceutical Service Product Portfolio Table 127. Lonza Recent Development Table 128. Abzena Company Information Table 129. Abzena Business Overview Table 130. Abzena Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Abzena Mammalian Biopharmaceutical Service Product Portfolio Table 132. Abzena Recent Development Table 133. AGC Biologics Company Information Table 134. AGC Biologics Business Overview Table 135. AGC Biologics Mammalian Biopharmaceutical Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. AGC Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 137. AGC Biologics Recent Development Table 138. North America Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Mammalian Biopharmaceutical Service Market Share by Country (2021-2026) Table 141. North America Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Mammalian Biopharmaceutical Service Market Share Forecast by Country (2027-2032) Table 143. Europe Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Mammalian Biopharmaceutical Service Market Share by Country (2021-2026) Table 146. Europe Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Mammalian Biopharmaceutical Service Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Mammalian Biopharmaceutical Service Market Share by Country (2021-2026) Table 151. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Mammalian Biopharmaceutical Service Market Share Forecast by Country (2027-2032) Table 153. Latin America Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Mammalian Biopharmaceutical Service Market Share by Country (2021-2026) Table 156. Latin America Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Mammalian Biopharmaceutical Service Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country (2021-2026) Table 161. Middle East & Africa Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Mammalian Biopharmaceutical Service Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Mammalian Biopharmaceutical Service Product Image Figure 3. Global Mammalian Biopharmaceutical Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Mammalian Biopharmaceutical Service Market Share by Region: 2025 VS 2032 Figure 6. Global Mammalian Biopharmaceutical Service Market Share by Region (2021-2032) Figure 7. North America Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cell Line Development Image Figure 13. Global Cell Line Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Analytical Testing Image Figure 15. Global Analytical Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Technology Transfer Image Figure 17. Global Technology Transfer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Formulation Development Image Figure 19. Global Formulation Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Mammalian Biopharmaceutical Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Mammalian Biopharmaceutical Service Market Share by Type 2025 VS 2032 Figure 24. North America Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032) Figure 25. Europe Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032) Figure 27. Latin America Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032) Figure 29. Pharmaceutical Image Figure 30. Global Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Contract Research Organizations (CROs) Image Figure 32. Global Contract Research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Academic and Research Institutes Image Figure 34. Global Academic and Research Institutes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Biotechnology Companies Image Figure 36. Global Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Government Agencies Image Figure 38. Global Government Agencies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Mammalian Biopharmaceutical Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Mammalian Biopharmaceutical Service Market Share by Application 2025 VS 2032 Figure 41. North America Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032) Figure 42. Europe Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032) Figure 44. Latin America Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Mammalian Biopharmaceutical Service Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Mammalian Biopharmaceutical Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Mammalian Biopharmaceutical Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 51. Europe Mammalian Biopharmaceutical Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Mammalian Biopharmaceutical Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 54. Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Mammalian Biopharmaceutical Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 57. Latin America Mammalian Biopharmaceutical Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Mammalian Biopharmaceutical Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 60. Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Line Development
  • Analytical Testing
  • Technology Transfer
  • Formulation Development
  • Others
Applications
  • Pharmaceutical
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Biotechnology Companies
  • Government Agencies
Companies covered
  • Novartis
  • KBI Biopharma
  • 3P Biopharmaceuticals
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Rentschler Biopharma SE
  • Northway Biotech
  • Cambrex
  • Samsung Biologics
  • FUJIFILM Diosynth Biotechnologies
  • GBI
  • Thermo Fisher Scientific
  • Catalent
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Lonza
  • Abzena
  • AGC Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Mammalian Biopharmaceutical Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Mammalian Biopharmaceutical Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Mammalian Biopharmaceutical Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Mammalian Biopharmaceutical Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Mammalian Biopharmaceutical Service Market Size (2021-2032)
  8. 1.5.1 North America Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Mammalian Biopharmaceutical Service Market Size Growth Rate (2021-2032)
2 Mammalian Biopharmaceutical Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cell Line Development
  3. 2.1.2 Analytical Testing
  4. 2.1.3 Technology Transfer
  5. 2.1.4 Formulation Development
  6. 2.1.5 Others
  7. 2.2 Global Mammalian Biopharmaceutical Service Market Size by Type
  8. 2.2.1 Global Mammalian Biopharmaceutical Service Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Mammalian Biopharmaceutical Service Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Mammalian Biopharmaceutical Service Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Mammalian Biopharmaceutical Service Market Size by Regions
  12. 2.3.1 North America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Type (2021-2026)
3 Mammalian Biopharmaceutical Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical
  3. 3.1.2 Contract Research Organizations (CROs)
  4. 3.1.3 Academic and Research Institutes
  5. 3.1.4 Biotechnology Companies
  6. 3.1.5 Government Agencies
  7. 3.2 Global Mammalian Biopharmaceutical Service Market Size by Application
  8. 3.2.1 Global Mammalian Biopharmaceutical Service Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Mammalian Biopharmaceutical Service Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Mammalian Biopharmaceutical Service Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Mammalian Biopharmaceutical Service Market Size by Regions
  12. 3.3.1 North America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Mammalian Biopharmaceutical Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Mammalian Biopharmaceutical Service Industry Trends
  2. 4.2 Mammalian Biopharmaceutical Service Industry Drivers
  3. 4.3 Mammalian Biopharmaceutical Service Industry Opportunities and Challenges
  4. 4.4 Mammalian Biopharmaceutical Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Mammalian Biopharmaceutical Service Revenue (2021-2026)
  2. 5.2 Global Mammalian Biopharmaceutical Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Mammalian Biopharmaceutical Service Key Company Headquarters & Area Served
  4. 5.4 Global Mammalian Biopharmaceutical Service Company, Product Type & Application
  5. 5.5 Global Mammalian Biopharmaceutical Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Mammalian Biopharmaceutical Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Mammalian Biopharmaceutical Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Mammalian Biopharmaceutical Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Mammalian Biopharmaceutical Service Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 KBI Biopharma
  8. 6.2.1 KBI Biopharma Company Information
  9. 6.2.2 KBI Biopharma Business Overview
  10. 6.2.3 KBI Biopharma Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 KBI Biopharma Mammalian Biopharmaceutical Service Product Portfolio
  12. 6.2.5 KBI Biopharma Recent Developments
  13. 6.3 3P Biopharmaceuticals
  14. 6.3.1 3P Biopharmaceuticals Company Information
  15. 6.3.2 3P Biopharmaceuticals Business Overview
  16. 6.3.3 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product Portfolio
  18. 6.3.5 3P Biopharmaceuticals Recent Developments
  19. 6.4 Sartorius Stedim Biotech
  20. 6.4.1 Sartorius Stedim Biotech Company Information
  21. 6.4.2 Sartorius Stedim Biotech Business Overview
  22. 6.4.3 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product Portfolio
  24. 6.4.5 Sartorius Stedim Biotech Recent Developments
  25. 6.5 Merck Millipore
  26. 6.5.1 Merck Millipore Company Information
  27. 6.5.2 Merck Millipore Business Overview
  28. 6.5.3 Merck Millipore Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck Millipore Mammalian Biopharmaceutical Service Product Portfolio
  30. 6.5.5 Merck Millipore Recent Developments
  31. 6.6 Rentschler Biopharma SE
  32. 6.6.1 Rentschler Biopharma SE Company Information
  33. 6.6.2 Rentschler Biopharma SE Business Overview
  34. 6.6.3 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product Portfolio
  36. 6.6.5 Rentschler Biopharma SE Recent Developments
  37. 6.7 Northway Biotech
  38. 6.7.1 Northway Biotech Company Information
  39. 6.7.2 Northway Biotech Business Overview
  40. 6.7.3 Northway Biotech Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Northway Biotech Mammalian Biopharmaceutical Service Product Portfolio
  42. 6.7.5 Northway Biotech Recent Developments
  43. 6.8 Cambrex
  44. 6.8.1 Cambrex Company Information
  45. 6.8.2 Cambrex Business Overview
  46. 6.8.3 Cambrex Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cambrex Mammalian Biopharmaceutical Service Product Portfolio
  48. 6.8.5 Cambrex Recent Developments
  49. 6.9 Samsung Biologics
  50. 6.9.1 Samsung Biologics Company Information
  51. 6.9.2 Samsung Biologics Business Overview
  52. 6.9.3 Samsung Biologics Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Samsung Biologics Mammalian Biopharmaceutical Service Product Portfolio
  54. 6.9.5 Samsung Biologics Recent Developments
  55. 6.10 FUJIFILM Diosynth Biotechnologies
  56. 6.10.1 FUJIFILM Diosynth Biotechnologies Company Information
  57. 6.10.2 FUJIFILM Diosynth Biotechnologies Business Overview
  58. 6.10.3 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product Portfolio
  60. 6.10.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  61. 6.11 GBI
  62. 6.11.1 GBI Company Information
  63. 6.11.2 GBI Business Overview
  64. 6.11.3 GBI Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GBI Mammalian Biopharmaceutical Service Product Portfolio
  66. 6.11.5 GBI Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Mammalian Biopharmaceutical Service Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
  73. 6.13 Catalent
  74. 6.13.1 Catalent Company Information
  75. 6.13.2 Catalent Business Overview
  76. 6.13.3 Catalent Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Catalent Mammalian Biopharmaceutical Service Product Portfolio
  78. 6.13.5 Catalent Recent Developments
  79. 6.14 WuXi Biologics
  80. 6.14.1 WuXi Biologics Company Information
  81. 6.14.2 WuXi Biologics Business Overview
  82. 6.14.3 WuXi Biologics Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 WuXi Biologics Mammalian Biopharmaceutical Service Product Portfolio
  84. 6.14.5 WuXi Biologics Recent Developments
  85. 6.15 Boehringer Ingelheim BioXcellence
  86. 6.15.1 Boehringer Ingelheim BioXcellence Company Information
  87. 6.15.2 Boehringer Ingelheim BioXcellence Business Overview
  88. 6.15.3 Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Product Portfolio
  90. 6.15.5 Boehringer Ingelheim BioXcellence Recent Developments
  91. 6.16 Lonza
  92. 6.16.1 Lonza Company Information
  93. 6.16.2 Lonza Business Overview
  94. 6.16.3 Lonza Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Lonza Mammalian Biopharmaceutical Service Product Portfolio
  96. 6.16.5 Lonza Recent Developments
  97. 6.17 Abzena
  98. 6.17.1 Abzena Company Information
  99. 6.17.2 Abzena Business Overview
  100. 6.17.3 Abzena Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Abzena Mammalian Biopharmaceutical Service Product Portfolio
  102. 6.17.5 Abzena Recent Developments
  103. 6.18 AGC Biologics
  104. 6.18.1 AGC Biologics Company Information
  105. 6.18.2 AGC Biologics Business Overview
  106. 6.18.3 AGC Biologics Mammalian Biopharmaceutical Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 AGC Biologics Mammalian Biopharmaceutical Service Product Portfolio
  108. 6.18.5 AGC Biologics Recent Developments
7 North America
  1. 7.1 North America Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  3. 7.3 North America Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  3. 8.3 Europe Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  3. 10.3 South America Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Mammalian Biopharmaceutical Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst